UniProt ID | RBM28_HUMAN | |
---|---|---|
UniProt AC | Q9NW13 | |
Protein Name | RNA-binding protein 28 | |
Gene Name | RBM28 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 759 | |
Subcellular Localization | Nucleus, nucleolus . | |
Protein Description | Nucleolar component of the spliceosomal ribonucleoprotein complexes.. | |
Protein Sequence | MAGLTLFVGRLPPSARSEQLEELFSQVGPVKQCFVVTEKGSKACRGFGYVTFSMLEDVQRALKEITTFEGCKINVTVAKKKLRNKTKEKGKNENSECPKKEPKAKKAKVADKKARLIIRNLSFKCSEDDLKTVFAQFGAVLEVNIPRKPDGKMRGFGFVQFKNLLEAGKALKGMNMKEIKGRTVAVDWAVAKDKYKDTQSVSAIGEEKSHESKHQESVKKKGREEEDMEEEENDDDDDDDDEEDGVFDDEDEEEENIESKVTKPVQIQKRAVKRPAPAKSSDHSEEDSDLEESDSIDDGEELAQSDTSTEEQEDKAVQVSNKKKRKLPSDVNEGKTVFIRNLSFDSEEEELGELLQQFGELKYVRIVLHPDTEHSKGCAFAQFMTQEAAQKCLLAASPENEAGGLKLDGRQLKVDLAVTRDEAAKLQTTKVKKPTGTRNLYLAREGLIRAGTKAAEGVSAADMAKRERFELLKHQKLKDQNIFVSRTRLCLHNLPKAVDDKQLRKLLLSATSGEKGVRIKECRVMRDLKGVHGNMKGQSLGYAFAEFQEHEHALKALRLINNNPEIFGPLKRPIVEFSLEDRRKLKMKELRIQRSLQKMRSKPATGEPQKGQPEPAKDQQQKAAQHHTEEQSKVPPEQKRKAGSTSWTGFQTKAEVEQVELPDGKKRRKVLALPSHRGPKIRLRDKGKVKPVHPKKPKPQINQWKQEKQQLSSEQVSRKKAKGNKTETRFNQLVEQYKQKLLGPSKGAPLAKRSKWFDS | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGLTLFVG ------CCCCEEEEE | 23.00 | - | |
39 | Ubiquitination | QCFVVTEKGSKACRG EEEEEEECCCHHCCC | 60.15 | - | |
39 | Acetylation | QCFVVTEKGSKACRG EEEEEEECCCHHCCC | 60.15 | 26051181 | |
66 | Phosphorylation | QRALKEITTFEGCKI HHHHHHCCCCCCCCE | 26.90 | 23401153 | |
79 | 2-Hydroxyisobutyrylation | KINVTVAKKKLRNKT CEEEEHHHHHHHHHH | 46.21 | - | |
79 | Acetylation | KINVTVAKKKLRNKT CEEEEHHHHHHHHHH | 46.21 | 25953088 | |
95 | Phosphorylation | EKGKNENSECPKKEP HCCCCCCCCCCCCCC | 34.10 | - | |
122 | Phosphorylation | RLIIRNLSFKCSEDD HHHHHCCCCCCCHHH | 26.63 | 21712546 | |
124 | Acetylation | IIRNLSFKCSEDDLK HHHCCCCCCCHHHHH | 33.21 | 26051181 | |
132 | Phosphorylation | CSEDDLKTVFAQFGA CCHHHHHHHHHHHCC | 28.31 | 20068231 | |
147 | Methylation | VLEVNIPRKPDGKMR EEEEECCCCCCCCCC | 60.38 | 24381713 | |
154 | Methylation | RKPDGKMRGFGFVQF CCCCCCCCCEEEEEH | 40.55 | 24381721 | |
162 | Ubiquitination | GFGFVQFKNLLEAGK CEEEEEHHHHHHHHH | 29.60 | - | |
162 | Acetylation | GFGFVQFKNLLEAGK CEEEEEHHHHHHHHH | 29.60 | 26051181 | |
172 | Ubiquitination | LEAGKALKGMNMKEI HHHHHHHCCCCHHHH | 62.06 | - | |
195 | Phosphorylation | WAVAKDKYKDTQSVS HHHHHHHCCCCCCCH | 24.99 | 23186163 | |
196 | 2-Hydroxyisobutyrylation | AVAKDKYKDTQSVSA HHHHHHCCCCCCCHH | 61.10 | - | |
198 | Phosphorylation | AKDKYKDTQSVSAIG HHHHCCCCCCCHHHC | 20.70 | 25850435 | |
200 | Phosphorylation | DKYKDTQSVSAIGEE HHCCCCCCCHHHCCH | 21.82 | 25850435 | |
202 | Phosphorylation | YKDTQSVSAIGEEKS CCCCCCCHHHCCHHC | 21.29 | 25159151 | |
263 | Acetylation | NIESKVTKPVQIQKR CHHHCCCCCHHHHHH | 46.29 | 26051181 | |
280 | Phosphorylation | KRPAPAKSSDHSEED CCCCCCCCCCCCCCC | 43.00 | 24144214 | |
281 | Phosphorylation | RPAPAKSSDHSEEDS CCCCCCCCCCCCCCC | 38.34 | 24144214 | |
284 | Phosphorylation | PAKSSDHSEEDSDLE CCCCCCCCCCCCCCC | 47.90 | 24144214 | |
288 | Phosphorylation | SDHSEEDSDLEESDS CCCCCCCCCCCCCCC | 47.58 | 30576142 | |
293 | Phosphorylation | EDSDLEESDSIDDGE CCCCCCCCCCCCCHH | 27.55 | 30576142 | |
295 | Phosphorylation | SDLEESDSIDDGEEL CCCCCCCCCCCHHHH | 36.88 | 30576142 | |
305 | Phosphorylation | DGEELAQSDTSTEEQ CHHHHHHCCCCCHHH | 36.93 | 18452278 | |
307 | Phosphorylation | EELAQSDTSTEEQED HHHHHCCCCCHHHHH | 42.68 | 18452278 | |
308 | Phosphorylation | ELAQSDTSTEEQEDK HHHHCCCCCHHHHHH | 38.52 | 24461736 | |
329 | Phosphorylation | KKKRKLPSDVNEGKT CCCCCCCCCCCCCCE | 65.70 | 28555341 | |
343 | Phosphorylation | TVFIRNLSFDSEEEE EEEEEECCCCCCHHH | 30.47 | 28464451 | |
346 | Phosphorylation | IRNLSFDSEEEELGE EEECCCCCCHHHHHH | 44.92 | 28464451 | |
376 | Acetylation | HPDTEHSKGCAFAQF CCCCCCCCCCHHHHH | 60.97 | 26051181 | |
397 | Phosphorylation | QKCLLAASPENEAGG HHHHHHCCCCCCCCC | 27.43 | 28112733 | |
406 | Acetylation | ENEAGGLKLDGRQLK CCCCCCEEECCCEEE | 48.05 | 26051181 | |
419 | Phosphorylation | LKVDLAVTRDEAAKL EEEEEEECHHHHHHH | 27.13 | 20068231 | |
459 | Phosphorylation | TKAAEGVSAADMAKR CHHHCCCCHHHHHHH | 28.70 | - | |
465 | 2-Hydroxyisobutyrylation | VSAADMAKRERFELL CCHHHHHHHHHHHHH | 48.42 | - | |
473 | Methylation | RERFELLKHQKLKDQ HHHHHHHHHCCCCCC | 57.52 | 115976435 | |
478 | Malonylation | LLKHQKLKDQNIFVS HHHHCCCCCCCEEEC | 65.39 | 26320211 | |
496 | Acetylation | LCLHNLPKAVDDKQL HHHHCCCCCCCHHHH | 65.30 | 26051181 | |
509 | Phosphorylation | QLRKLLLSATSGEKG HHHHHHHHCCCCCCC | 29.48 | 20068231 | |
511 | Phosphorylation | RKLLLSATSGEKGVR HHHHHHCCCCCCCCE | 33.61 | 20068231 | |
512 | Phosphorylation | KLLLSATSGEKGVRI HHHHHCCCCCCCCEE | 44.67 | 25627689 | |
515 | Acetylation | LSATSGEKGVRIKEC HHCCCCCCCCEEEEE | 67.25 | 25953088 | |
571 | 2-Hydroxyisobutyrylation | PEIFGPLKRPIVEFS CCCCCCCCCCEEECC | 60.30 | - | |
595 | Phosphorylation | KELRIQRSLQKMRSK HHHHHHHHHHHHHCC | 20.83 | 27134283 | |
622 | Acetylation | PAKDQQQKAAQHHTE CCHHHHHHHHHHHCH | 41.15 | 20167786 | |
639 | Acetylation | SKVPPEQKRKAGSTS HCCCHHHHCCCCCCC | 54.96 | 20167786 | |
644 | Phosphorylation | EQKRKAGSTSWTGFQ HHHCCCCCCCCCCCC | 24.91 | 25159151 | |
645 | Phosphorylation | QKRKAGSTSWTGFQT HHCCCCCCCCCCCCC | 27.63 | 25627689 | |
646 | Phosphorylation | KRKAGSTSWTGFQTK HCCCCCCCCCCCCCC | 25.08 | 25159151 | |
653 | Sumoylation | SWTGFQTKAEVEQVE CCCCCCCCEEEEEEE | 31.59 | 28112733 | |
665 | 2-Hydroxyisobutyrylation | QVELPDGKKRRKVLA EEECCCCCCEEEEEE | 50.95 | - | |
665 | Acetylation | QVELPDGKKRRKVLA EEECCCCCCEEEEEE | 50.95 | 26051181 | |
675 | Phosphorylation | RKVLALPSHRGPKIR EEEEECCCCCCCCEE | 27.02 | 28555341 | |
705 | Sumoylation | KPQINQWKQEKQQLS CCCHHHHHHHHHHHC | 38.52 | - | |
705 | Methylation | KPQINQWKQEKQQLS CCCHHHHHHHHHHHC | 38.52 | 110873973 | |
705 | Sumoylation | KPQINQWKQEKQQLS CCCHHHHHHHHHHHC | 38.52 | - | |
708 | Ubiquitination | INQWKQEKQQLSSEQ HHHHHHHHHHHCHHH | 40.63 | - | |
712 | Phosphorylation | KQEKQQLSSEQVSRK HHHHHHHCHHHHHHH | 27.73 | 29743597 | |
713 | Phosphorylation | QEKQQLSSEQVSRKK HHHHHHCHHHHHHHH | 40.41 | 29255136 | |
717 | Phosphorylation | QLSSEQVSRKKAKGN HHCHHHHHHHHHCCC | 37.77 | 29255136 | |
738 | Ubiquitination | NQLVEQYKQKLLGPS HHHHHHHHHHHHCCC | 40.42 | - | |
745 | Phosphorylation | KQKLLGPSKGAPLAK HHHHHCCCCCCCHHH | 41.76 | 29396449 | |
746 | Malonylation | QKLLGPSKGAPLAKR HHHHCCCCCCCHHHH | 63.33 | 32601280 | |
755 | Methylation | APLAKRSKWFDS--- CCHHHHCCCCCC--- | 56.78 | 115976447 | |
759 | Phosphorylation | KRSKWFDS------- HHCCCCCC------- | 32.42 | 21712546 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of RBM28_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of RBM28_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of RBM28_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
RL5_HUMAN | RPL5 | physical | 22939629 | |
RS17_HUMAN | RPS17 | physical | 22939629 | |
RRP12_HUMAN | RRP12 | physical | 22939629 | |
RPC6_HUMAN | POLR3F | physical | 22939629 | |
RPC7_HUMAN | POLR3G | physical | 22939629 | |
ZN622_HUMAN | ZNF622 | physical | 22939629 | |
NOP2_HUMAN | NOP2 | physical | 26344197 | |
PESC_HUMAN | PES1 | physical | 26344197 | |
SDA1_HUMAN | SDAD1 | physical | 26344197 | |
TOP1_HUMAN | TOP1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
612079 | Alopecia, neurologic defects, and endocrinopathy syndrome (ANES) | |||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND MASSSPECTROMETRY. | |
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis."; Wang B., Malik R., Nigg E.A., Korner R.; Anal. Chem. 80:9526-9533(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-202, AND MASSSPECTROMETRY. |